Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindu.com -  The Hindu Bureau - Two workers killed in chloroform vapour leak at pharma unit, TGPCB orders closure
Two workers killed in chloroform vapour leak at pharma unit, TGPCB orders closure
The Hindu –

Two employees of a pharmaceutical manufacturing unit were killed after being exposed to chloroform vapours that leaked during a production process at Saraca Laboratories Limited in the Gaddapotharam industrial area of Jinnaram mandal in Sangareddy…

marketbeat.com - Wall Street Zen Upgrades NervGen Pharma (NASDAQ:NGEN) to Sell
Wall Street Zen Upgrades NervGen Pharma (NASDAQ:NGEN) to Sell
MarketBeat –

NervGen Pharma (NASDAQ:NGEN - Get Free Report) was upgraded by research analysts at Wall Street Zen from a 'strong sell' rating to a 'sell' rating in a report issued on Saturday, Wall Street Zen reports. Several other analysts also recently weighed…

marketbeat.com - NewAmsterdam Pharma (NASDAQ:NAMS) Stock Bumped Down to Sell by Wall Street Zen
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Bumped Down to Sell by Wall Street Zen
MarketBeat –

NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a research note issued to investors on Saturday, Wall Street Zen reports. Several other…

thehindubusinessline.com - Centre sets up panel to review pharma marketing rules, examine need for stronger legal framework
Centre sets up panel to review pharma marketing rules, examine need for stronger legal framework
BusinessLine –

The Department of Pharmaceuticals has formed a three-member committee to look into the effectiveness of the existing framework governing pharmaceutical marketing practices and recommend measures to strengthen oversight, including the possibility of…

dev.to - Modern Industry Insights - Computer System Validation in Pharma: A Practical Guide to Risk-Based Testing
Computer System Validation in Pharma: A Practical Guide to Risk-Based Testing
DEV Community –

Software used in pharmaceutical operations does more than automate workflows. It may manage laboratory results, manufacturing records, quality processes, and other data that support regulated activities. When software affects product quality…

marketbeat.com - NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month Low - Here's What Happened
NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month Low - Here's What Happened
MarketBeat –

Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) hit a new 52-week low during mid-day trading on Saturday. The stock traded as low as $19.13 and last traded at $19.71, with a volume of 2,311,178 shares trading hands. The…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Stock Falls 5.9% - What's Next?
Avalyn Pharma (NASDAQ:AVLN) Stock Falls 5.9% - What's Next?
MarketBeat –

Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s share price dropped 5.9% on Friday. The company traded as low as $25.45 and last traded at $25.64. 67,070 shares changed hands during trading, a decline of 78% from the average session volume of…

marketbeat.com - Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Average Target Price of $36.25 According to Brokerages
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Average Target Price of $36.25 According to Brokerages
MarketBeat –

Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) have received an average rating of 'Moderate Buy' from the five ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a…

marketbeat.com - NewAmsterdam Pharma (NASDAQ:NAMS) Stock Falls 6.5% - What's Next?
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Falls 6.5% - What's Next?
MarketBeat –

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) shares dropped 6.5% during mid-day trading on Friday. The company traded as low as $20.23 and last traded at $20.1740. Approximately 268,142 shares were traded during trading, a…

rediff.com - Text Feed - Telangana Minister Highlights Gen Z's Role In AI And Green Innovation
Telangana Minister Highlights Gen Z's Role In AI And Green Innovation
Rediff.com –

Telangana IT Minister D Sridhar Babu has highlighted Gen Z's pivotal role in spearheading the next wave of AI and green innovation, urging young minds to leverage technology for sustainable solutions through the newly launched Green Skills and…

thehindu.com -  The Hindu Bureau - CoE on green skills, Applied AI opened
CoE on green skills, Applied AI opened
The Hindu –

IT and Industries Minister D. Sridhar Babu on Friday inaugurated a Green Skills and Applied AI Centre of Excellence in Hyderabad. The facility forms part of a national network of five such centres of excellence established by 1M1B and Microsoft in…

nypost.com - McKenzie Beard - Exclusive | MDMA-assisted therapy could get FDA approval as soon as January, top advocate predicts - but there's a major problem looming
Exclusive | MDMA-assisted therapy could get FDA approval as soon as January, top advocate predicts - but there's a major problem looming
New York Post –

A drug once synonymous with rave culture could soon be making its way into a very different setting: the therapist's office. A leading psychedelics advocate is “very optimistic” the Food and Drug Administration could approve…

thehindubusinessline.com - Microsoft, MeitY Startup Hub, 1M1B launch Green Skills, Applied AI Centre in Hyd
Microsoft, MeitY Startup Hub, 1M1B launch Green Skills, Applied AI Centre in Hyd
BusinessLine –

The Ministry of Information Technology (IT), Industries & Commerce, along with the 1M1B Foundation, in partnership with MeitY Startup Hub and Microsoft, inaugurated the Green Skills & Applied AI Centre of Excellence (CoE) here on Friday. With a…

medpagetoday.com - Which Biologic Provides the Best Outcomes for Psoriasis in High-Impact Areas?
Which Biologic Provides the Best Outcomes for Psoriasis in High-Impact Areas?
Medpage Today –

In adults with moderate-to-severe plaque psoriasis in high-impact areas, treatment with bimekizumab (Bimzelx) -- a selective dual inhibitor of interleukin (IL)-17A and IL-17F -- demonstrated a rapid response with higher rates of complete clearance…

forbes.com - Expert Panel - How To Build A Less Polished, More Participatory Brand Community
How To Build A Less Polished, More Participatory Brand Community
Forbes –

Audiences have grown wary of content that feels overly polished, scripted and tightly controlled by the brand behind it. Moreover, consumers want to be heard, not just sold to, and they can quickly tell when “engagement” is being…

Receive a Daily briefing on Pharma Industry News

Get Started